Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6025.5000 65.00 (1.09%)
NSE May 09, 2025 15:31 PM
Volume: 450.0K
 

6025.50
1.09%
Karvy
Revenues in line, margins outperform: Divis Lab's net revenues increased by 1.9% YoY to Rs 10.8 bn, marginallylower than our estimates of Rs 10.9 bn for the quarter. The operating marginswere at 35.5% in Q4FY18 (higher than our estimate of 33.9%) as against 34%in Q4FY17 on account of lower raw material cost and other expenses.
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended